These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 9806260

  • 1. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE, Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K, Lolis D.
    Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
    [Abstract] [Full Text] [Related]

  • 2. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 3. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle.
    Messinis IE, Lolis D, Zikopoulos K, Milingos S, Kollios G, Seferiadis K, Templeton AA.
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):169-75. PubMed ID: 8849571
    [Abstract] [Full Text] [Related]

  • 4. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 5. Attenuating activity of the ovary on LH response to GnRH during the follicular phase of the cycle.
    Dimitraki M, Messini CI, Dafopoulos K, Gioka T, Koutlaki N, Garas A, Georgoulias P, Messinis IE.
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):439-43. PubMed ID: 23909480
    [Abstract] [Full Text] [Related]

  • 6. Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone.
    Messinis IE, Lolis D, Zikopoulos K, Tsahalina E, Seferiadis K, Templeton AA.
    Hum Reprod; 1994 Aug; 9(8):1437-41. PubMed ID: 7989501
    [Abstract] [Full Text] [Related]

  • 7. Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women.
    Messinis IE, Lolis D, Papadopoulos L, Tsahalina T, Papanikolaou N, Seferiadis K, Templeton AA.
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):45-50. PubMed ID: 8348707
    [Abstract] [Full Text] [Related]

  • 8. Follicle stimulating hormone stimulates the production of gonadotrophin surge attenuating factor (GnSAF) in vivo.
    Messinis IE, Hirsch P, Templeton AA.
    Clin Endocrinol (Oxf); 1991 Nov; 35(5):403-7. PubMed ID: 1814653
    [Abstract] [Full Text] [Related]

  • 9. Activity of gonadotrophin surge-attenuating factor during the luteal phase in superovulated women.
    Messinis IE, MacTavish A, Templeton AA.
    J Reprod Fertil; 1993 Jan; 97(1):271-5. PubMed ID: 8464020
    [Abstract] [Full Text] [Related]

  • 10. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
    Itskovitz-Eldor J, Kol S, Mannaerts B.
    Hum Reprod; 2000 Sep; 15(9):1965-8. PubMed ID: 10966996
    [Abstract] [Full Text] [Related]

  • 11. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
    Alexandris E, Milingos S, Kollios G, Seferiadis K, Lolis D, Messinis IE.
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
    [Abstract] [Full Text] [Related]

  • 12. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

  • 13. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN, Phung HT, Ho MT.
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [Abstract] [Full Text] [Related]

  • 14. Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role.
    Dafopoulos K, Kotsovassilis CG, Milingos S, Kallitsaris A, Galazios G, Zintzaras E, Sotiros P, Messinis IE.
    Hum Reprod; 2004 Sep; 19(9):1985-92. PubMed ID: 15229199
    [Abstract] [Full Text] [Related]

  • 15. Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone.
    Messinis IE, Templeton AA.
    Hum Reprod; 1987 Jan; 2(1):11-6. PubMed ID: 3106404
    [Abstract] [Full Text] [Related]

  • 16. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R.
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [Abstract] [Full Text] [Related]

  • 17. Higher gonadotrophin surge-attenuating factor bioactivity is found in small follicles from superovulated women.
    Fowler PA, Fraser M, Cunningham P, Knight PG, Byrne B, McLaughlin EA, Wardle PG, Hull MG, Templeton A.
    J Endocrinol; 1994 Oct; 143(1):33-44. PubMed ID: 7964320
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S, Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism.
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [Abstract] [Full Text] [Related]

  • 19. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S, Gunby J.
    Cochrane Database Syst Rev; 2000 Dec; (4):CD002810. PubMed ID: 11034767
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.